Republican lawmakers have proposed a raft of cost-cutting measures that could limit access to Medicaid and Medicare. Why It Matters Funding cuts and regulatory changes could radically reduce Medicaid,

Protect Our Care, a liberal advocacy group, is launching a $10 million “Hands Off Medicaid” campaign that targets 17 GOP lawmakers.

Donald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.

The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by introducing floors.

Medicare and Medicaid are major sources of government spending, yet Democrats and Republicans alike support funding the programs.

The Centers for Medicare & Medicaid Services on Friday released an informational bulletin with updated federal poverty level standards applied to eligibility criteria for Medicaid.

Expanding eligibility for MSPs is an important avenue to support health care affordability for older low-income adults, including those that are dually eligible for Medicare and Medicaid.

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.

The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started, so current drug prices are unaffected.

Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.

The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.